Ethiopia: Our Impact

 {Photo credit: Hatoluf Melkamu}Temesgen Zewdu visits Keta Health Center to pick up his TB medicines and care for the plant dedicated to him.Photo credit: Hatoluf Melkamu

Betiglu Legesse is always trying to ensure that the patients he cares for stay on their tuberculosis (TB) treatment from beginning to end. It’s a challenge: In 2020 alone, more than 60 of his patients stopped their treatments, often due to many interplaying factors, such as forgetfulness, length of the treatment itself, fear of side effects, and a long distance to the health facility. Betiglu works as a TB focal person at the about 50 kilometers east of Ethiopia’s capital city, Addis Ababa.

 {Photo credit: MSH staff}Internal displaced people being screened for TB, COVID-19, and HIV in 1 of the 10 centers for internally displaced people in Mekelle, Tigray.Photo credit: MSH staff

The major conflict in Ethiopia’s Tigray region is affecting the functionality of the region’s health system, impacting everything from human resources to infrastructure. TB services are no exception. TB client follow-up has been disrupted, and many facilities have been damaged, including laboratory diagnostic equipment like microscopes and GeneXpert machines. The capacity to ensure service continuity and collect monitoring and evaluation data has been compromised.

{Photo Credit: Warren Zelman}Photo Credit: Warren Zelman

By Berhanemeskal Assefa Woldemariam, Principal Technical Advisor, Management Sciences for HealthAs a country with high rates of tuberculosis (TB), Ethiopia is working to expand services and improve TB case finding.

Left to right: Dr. Daniel Gemechu, Regional Director for CTB/Ethiopia , Dr. Ahmed Bedru, Country Director for CTB/Ethiopia , Mr. Taye Letta, National TB Program Manager, Dr. Liya Tadesse, State Minister of Health, Dr. Kitty van Weezenbeek, Executive Director of KNCV and Dr. Pedro Suarez, Senior Director, Infectious Disease Cluster at MSH.

At last week’s end of project ceremony, the USAID-funded Challenge TB project celebrated improvements in Ethiopia’s ability to save lives by detecting, diagnosing, and treating TB more effectively.Under this five-year program, USAID invested $42 million to improve the quality of TB care and prevention services, enabling patients to receive better access to treatment and medication to fight the disease. TB deaths have dropped significantly as treatment success rates rose above 90%, with 75% of those suffering from multidrug-resistant TB now able to beat the disease after comple

Tuberculosis remains the world’s leading infectious disease killer, claiming 4,500 lives each day. Every year, some 558,000 people will develop a form of TB that is resistant to rifampicin, the most effective first-line drug, making successful treatment of the disease even more difficult and costly. Ending the global epidemic requires a comprehensive approach, rapid innovation and proven interventions, bold leadership, and intensive community engagement.

 {Photo credit: Tsion Issayas/MSH}Dr. Degu (far right) answers questions raised from the audience in a lively discussion during his presentation at the 13th Annual TB Research Conference in Addis Ababa.Photo credit: Tsion Issayas/MSH

The 13th Annual TB Research Conference in Ethiopia took place from 21-24 March in Addis Ababa. Organized by the Ethiopian Public Health Institute in collaboration with the Federal Ministry of Health, the TB Research Conference is a forum designed to promote discussion and share innovations toward strengthening national response to the spread of tuberculosis. The conference was also part of the World TB Day celebrations that took place nationwide.

 {Photo credit: Warren Zelman}Ethiopia is making progress in tackling tuberculosis, the leading infectious disease killer along with HIV.Photo credit: Warren Zelman

This week, MSH is joining researchers, advocates, civil society, scientists, healthcare professionals, and students working on all aspects of lung health around the world in Guadalajara, Mexico for the 48th Union World Conference on Lung Health, where tuberculosis is the key topic. Tuberculosis (TB) is one of the top 10 causes of death worldwide, with over 95% of TB deaths occurring in low- and middle-income countries. Although tremendous progress has been made in the ongoing fight against this disease, some key segments of the population continue to shoulder the burden of TB more acutely.

{Photo Credit: Tsion Issayas/MSH}    Consortium members of Community HIV Care and Treatment Project, USAID Mission Director and the State Minister of Health hand in hand for a successful partnership.Photo Credit: Tsion Issayas/MSH

The Community HIV Care and Treatment Project in Ethiopia was launched on September 19, 2017. The event was attended by the State Minister of Health Dr. Kebede Worku, USAID’S Mission Director Leslie Reed, consortium members, and implementing partners.

 {Graphic: African Strategies for Health}Officials from nine African countries convened in Ghana to find solutions to common challenges of attaining universal health coverage (UHC) with sustainability and improved quality of care.Graphic: African Strategies for Health

by African Strategies for Health The goals of universal health coverage (UHC) can only be delivered when access to health services and financial risk protection are equitably addressed.

{Photo Credit: MSH Staff}Photo Credit: MSH Staff

Management Sciences for Health has been working closely in collaboration with the Global Alliance for TB Drug Development (TB Alliance) on the introduction of the new dispersible pediatric fixed-dose combination. Through MSH’s projects across identified high-burden countries, we have been providing assistance on updating treatment guidelines and essential medicines lists, registration of the reformulated product, financing and reprogramming grants, quantification, and training healthcare providers on the medicine and its use. 

Pages